基于因子分析法的医药流通行业综合竞争力评价研究  

Evaluation of the comprehensive competitiveness of pharmaceutical distribution companies based on the factor analysis

作　　者：卢嘉圆 

机构地区：[1]国药控股分销中心有限公司,上海200051

出　　处：《上海医药》2016年第7期73-77,共5页Shanghai Medical & Pharmaceutical Journal

摘　　要：在整个药品产业链中,医药流通企业起到承上启下的作用,研究医药流通企业的竞争力及其影响因素,并找到提升方法,不仅能使个体公司在激烈的竞争中脱颖而出,而且能提高整个药品供应链的效率。本文选择在A股市场上市的以药品分销为主营业务的企业作为研究对象,应用因子分析方法对2015年半年报数据进行研究,一方面对各公司进行竞争力评价,另一方面挖掘数据背后的原因,并在此基础上提出对医药流通行业未来发展的思考。Pharmaceutical distribution companies serve as a connecting link in the whole chains of pharmaceutical industry. Studying the comprehensive competitiveness and its influence factors, and then finding the improvement approaches can help not only the individual company stand out, but also enhance the efficiency of the whole chains of pharmaceutical industry. The semiannual reports of year 2015 were studied by taking distribution companies with drug distribution for the main business and listed on the A stock market as an object and applying factor analysis to evaluate their comprehensive competitiveness. On the other hand, the thinking of future development for pharmaceutical distribution industry was also proposed based on the mined reasons behind these data.

关 键 词：医药流通企业 因子分析 竞争力 未来发展 

分 类 号：F426.72[经济管理—产业经济] R197.1[医药卫生—卫生事业管理]